Showing results (11-20 of 132) with videos related to
Sort By:
Pageof 14
Journal of HIV Therapy|July 9, 2004
Does atazanavir cause lipodystrophy?Brian G Gazzard, Graeme MoyleAIDS (London, England)|May 19, 2010
Does earlier HIV RNA suppression provide long-term benefits?Graeme Moyle, Ralph Demasi, Andrew HillAIDS Clinical Care|March 4, 2009
Antiretroviral rounds. Too many options?Sharon Walmsley, Timothy Wilkin, Graeme MoyleThorax|May 1, 2014
It's a MALDI but it's a goodie: MALDI-TOF mass spectrometry for microbial identificationPaul RandellExpert Opinion on Pharmacotherapy|May 23, 2015
HIV integrase inhibitors: a new era in the treatment of HIVJose Luis Blanco, Gary Whitlock, Ana Milinkovic, et al.Clinical Therapeutics|March 5, 2004
Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studiesGraeme Moyle, Will Sawyer, Matthew Law, et al.HIV Medicine|July 14, 2021
The benefits of tenofovir discontinuation with or without bisphosphonate therapy in osteoporotic people living with HIVJonathan Jin Hei Lei, Branca Pereira, Graeme Moyle, et al.Clinical Therapeutics|January 4, 2012
The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trialBarry S Peters, Anthony S Wierzbicki, Graeme Moyle, et al.Journal of the International AIDS Society|November 14, 2014
Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitorTristan Barber, Andrew Hill, Gurmit Jagjit Singh, et al.Antiviral Therapy|March 26, 2004
Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapyAntonio Pires, Jeffrey Pido-Lopez, Graeme Moyle, et al.Pageof 14